rep profile
rep profile
Chris Tremains
Company
Novartis Pharmaceuticals
Title
Territory representative
Current home
Columbus, OH
Territory:Â Columbus and Southern Ohio.
Customers:Â Primary care physicians, rheumatologists, OB/GYNs, endocrinologists and internists.
Awards:Â District sales award.
Selling techniques:Â "I tailor my presentation to fit the needs of each customer. Because a physician is giving me his or her valuable time, I feel it is important to give them valuable, concise information. I get to the point quickly. Also, I am always redoing my sales binder. I try to keep it fresh. Novartis provides motivational tapes for its employees, so I listen to these while I am in my car. I also read many different books on selling; one particular book I really like is 'Hardball Selling,' by Robert Schuck."
Sales philosophy:Â "I provide professional information about my products with all the staff in the doctor's office. I think it is important that my customers see me as a professional and know that I provide valuable information for their patients. Also, I don't run down the competition. I build a strong partnership with the physicians based on trust, ethics and credibility."
Teamwork and motivation:Â "I find teamwork to be very motivating. Working together as a team requires everyone to keep up their end of project. My co-workers and I provide daily reinforcement for each other."
Volunteer work:Â "I volunteer for Refugee Services. I teach English as a second language to immigrants, as well as Government and American history. This prepares them for their citizenship examination. It's neat to see our country through their eyes."
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.